Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10402461rdf:typepubmed:Citationlld:pubmed
pubmed-article:10402461lifeskim:mentionsumls-concept:C0120465lld:lifeskim
pubmed-article:10402461lifeskim:mentionsumls-concept:C1412510lld:lifeskim
pubmed-article:10402461lifeskim:mentionsumls-concept:C1415002lld:lifeskim
pubmed-article:10402461lifeskim:mentionsumls-concept:C0870432lld:lifeskim
pubmed-article:10402461lifeskim:mentionsumls-concept:C1705417lld:lifeskim
pubmed-article:10402461lifeskim:mentionsumls-concept:C0037791lld:lifeskim
pubmed-article:10402461lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:10402461lifeskim:mentionsumls-concept:C1555465lld:lifeskim
pubmed-article:10402461lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:10402461pubmed:issue1lld:pubmed
pubmed-article:10402461pubmed:dateCreated1999-8-9lld:pubmed
pubmed-article:10402461pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10402461pubmed:abstractTextExpression cloning from a cDNA library prepared from a mutant CHO cell line with Golgi-specific resistance to Brefeldin A (BFA) identified a novel 206-kD protein with a Sec7 domain termed GBF1 for Golgi BFA resistance factor 1. Overexpression of GBF1 allowed transfected cells to maintain normal Golgi morphology and grow in the presence of BFA. Golgi- enriched membrane fractions from such transfected cells displayed normal levels of ADP ribosylation factors (ARFs) activation and coat protein recruitment that were, however, BFA resistant. Hexahistidine-tagged-GBF1 exhibited BFA-resistant guanine nucleotide exchange activity that appears specific towards ARF5 at physiological Mg2+concentration. Characterization of cDNAs recovered from the mutant and wild-type parental lines established that transcripts in these cells had identical sequence and, therefore, that GBF1 was naturally BFA resistant. GBF1 was primarily cytosolic but a significant pool colocalized to a perinuclear structure with the beta-subunit of COPI. Immunogold labeling showed highest density of GBF1 over Golgi cisternae and significant labeling over pleiomorphic smooth vesiculotubular structures. The BFA-resistant nature of GBF1 suggests involvement in retrograde traffic.lld:pubmed
pubmed-article:10402461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10402461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10402461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10402461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10402461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10402461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10402461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10402461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10402461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10402461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10402461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10402461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10402461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10402461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10402461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10402461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10402461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10402461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10402461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10402461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10402461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10402461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10402461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10402461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10402461pubmed:languageenglld:pubmed
pubmed-article:10402461pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10402461pubmed:citationSubsetIMlld:pubmed
pubmed-article:10402461pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10402461pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10402461pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10402461pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10402461pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10402461pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10402461pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10402461pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10402461pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10402461pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10402461pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10402461pubmed:statusMEDLINElld:pubmed
pubmed-article:10402461pubmed:monthJullld:pubmed
pubmed-article:10402461pubmed:issn0021-9525lld:pubmed
pubmed-article:10402461pubmed:authorpubmed-author:BergerS JSJlld:pubmed
pubmed-article:10402461pubmed:authorpubmed-author:ShiE CEClld:pubmed
pubmed-article:10402461pubmed:authorpubmed-author:DahanSSlld:pubmed
pubmed-article:10402461pubmed:authorpubmed-author:ClaudeAAlld:pubmed
pubmed-article:10402461pubmed:authorpubmed-author:MelançonPPlld:pubmed
pubmed-article:10402461pubmed:authorpubmed-author:SullivanE MEMlld:pubmed
pubmed-article:10402461pubmed:authorpubmed-author:ZhaoB PBPlld:pubmed
pubmed-article:10402461pubmed:authorpubmed-author:KuziemskyC...lld:pubmed
pubmed-article:10402461pubmed:authorpubmed-author:ArmoldA DADlld:pubmed
pubmed-article:10402461pubmed:issnTypePrintlld:pubmed
pubmed-article:10402461pubmed:day12lld:pubmed
pubmed-article:10402461pubmed:volume146lld:pubmed
pubmed-article:10402461pubmed:ownerNLMlld:pubmed
pubmed-article:10402461pubmed:authorsCompleteYlld:pubmed
pubmed-article:10402461pubmed:pagination71-84lld:pubmed
pubmed-article:10402461pubmed:dateRevised2010-10-8lld:pubmed
pubmed-article:10402461pubmed:meshHeadingpubmed-meshheading:10402461...lld:pubmed
pubmed-article:10402461pubmed:meshHeadingpubmed-meshheading:10402461...lld:pubmed
pubmed-article:10402461pubmed:meshHeadingpubmed-meshheading:10402461...lld:pubmed
pubmed-article:10402461pubmed:meshHeadingpubmed-meshheading:10402461...lld:pubmed
pubmed-article:10402461pubmed:meshHeadingpubmed-meshheading:10402461...lld:pubmed
pubmed-article:10402461pubmed:meshHeadingpubmed-meshheading:10402461...lld:pubmed
pubmed-article:10402461pubmed:meshHeadingpubmed-meshheading:10402461...lld:pubmed
pubmed-article:10402461pubmed:meshHeadingpubmed-meshheading:10402461...lld:pubmed
pubmed-article:10402461pubmed:meshHeadingpubmed-meshheading:10402461...lld:pubmed
pubmed-article:10402461pubmed:meshHeadingpubmed-meshheading:10402461...lld:pubmed
pubmed-article:10402461pubmed:meshHeadingpubmed-meshheading:10402461...lld:pubmed
pubmed-article:10402461pubmed:meshHeadingpubmed-meshheading:10402461...lld:pubmed
pubmed-article:10402461pubmed:meshHeadingpubmed-meshheading:10402461...lld:pubmed
pubmed-article:10402461pubmed:meshHeadingpubmed-meshheading:10402461...lld:pubmed
pubmed-article:10402461pubmed:meshHeadingpubmed-meshheading:10402461...lld:pubmed
pubmed-article:10402461pubmed:meshHeadingpubmed-meshheading:10402461...lld:pubmed
pubmed-article:10402461pubmed:meshHeadingpubmed-meshheading:10402461...lld:pubmed
pubmed-article:10402461pubmed:meshHeadingpubmed-meshheading:10402461...lld:pubmed
pubmed-article:10402461pubmed:meshHeadingpubmed-meshheading:10402461...lld:pubmed
pubmed-article:10402461pubmed:meshHeadingpubmed-meshheading:10402461...lld:pubmed
pubmed-article:10402461pubmed:meshHeadingpubmed-meshheading:10402461...lld:pubmed
pubmed-article:10402461pubmed:meshHeadingpubmed-meshheading:10402461...lld:pubmed
pubmed-article:10402461pubmed:meshHeadingpubmed-meshheading:10402461...lld:pubmed
pubmed-article:10402461pubmed:meshHeadingpubmed-meshheading:10402461...lld:pubmed
pubmed-article:10402461pubmed:meshHeadingpubmed-meshheading:10402461...lld:pubmed
pubmed-article:10402461pubmed:meshHeadingpubmed-meshheading:10402461...lld:pubmed
pubmed-article:10402461pubmed:year1999lld:pubmed
pubmed-article:10402461pubmed:articleTitleGBF1: A novel Golgi-associated BFA-resistant guanine nucleotide exchange factor that displays specificity for ADP-ribosylation factor 5.lld:pubmed
pubmed-article:10402461pubmed:affiliationDepartment of Cell Biology, University of Alberta, Edmonton, Alberta, Canada, T6G 2H7.lld:pubmed
More...